Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

MIXED(5)

DRUG(1)

Questionnaire Administration

1 trial

phase_1

mayo-clinic

External Beam Radiation Therapy

Biospecimen Collection

6 unique interventions2 categories

Analytics

Trial Phases

Phase 11

Trial Status

Recruiting1

Role Distribution

Principal Investigator1

PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06997094Phase 1Recruiting

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

HPV-Negative Squamous Cell CarcinomaHuman Papillomavirus-Negative Neck Squamous Cell CarcinomaResectable Head and Neck Squamous Cell Carcinoma+2 more

PrincipalinvestigatorStart date: 2026-01-23

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

HPV-Negative Squamous Cell Carcinoma1 Human Papillomavirus-Negative Neck Squamous Cell Carcinoma1 Resectable Head and Neck Squamous Cell Carcinoma1 Resectable Head and Neck Squamous-cell Carcinoma1 Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma1

Affiliations

Mayo Clinic

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

8 similar investigators found

Shetal A Patel, MD

UNC Lineberger Comprehensive Cancer Center

1 trials

Shared therapeutic areas:

Resectable Head and Neck Squamous-cell Carcinoma

Similarity Score6%

Paul L Swiecicki

University of Michigan Rogel Cancer Center

1 trials

Shared therapeutic areas:

Resectable Head and Neck Squamous Cell Carcinoma

Similarity Score6%

Ari Rosenberg, MD

University of Chicago

5 trials

Shared therapeutic areas:

HPV-Negative Squamous Cell Carcinoma

Similarity Score6%

Dukagjin M Blakaj, MD, PhD

Ohio State University Comprehensive Cancer Center

1 trials

Shared therapeutic areas:

Resectable Head and Neck Squamous Cell Carcinoma

Similarity Score6%

Guangyuan Hu, professor

Tongji Hospital

1 trials

Shared therapeutic areas:

Resectable Head and Neck Squamous-cell Carcinoma

Similarity Score6%

Sana Karam, MD, PhD

Washington University School of Medicine

1 trials

Shared therapeutic areas:

HPV-Negative Squamous Cell Carcinoma

Similarity Score6%

Musaddiq Awan, MD

Medical College of Wisconsin

3 trials

Shared therapeutic areas:

Resectable Head and Neck Squamous Cell Carcinoma

Similarity Score6%

Sidharth Puram, MD, PhD

Washington University School of Medicine

1 trials

Shared therapeutic areas:

HPV-Negative Squamous Cell Carcinoma

Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06997094Phase 1PrincipalInvestigator

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

HPV-Negative Squamous Cell CarcinomaHuman Papillomavirus-Negative Neck Squamous Cell CarcinomaResectable Head and Neck Squamous Cell Carcinoma+2 more

Recruiting

All 1 trials loaded